Clinical Trial Update: Efficacy and Safety of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing moxidectin to ivermectin for strongyloidiasis has completed with posted results addressing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Strongyloides Stercoralis Infection

Drugs mentioned

• IVERMECTIN (Ivermectin)
• Moxidectin (moxidectin)

Snippet

Sponsor: Jennifer Keiser | Conditions: Strongyloides Stercoralis Infection | Phase 3 | Status: COMPLETED | Results posted: 2024-01-24